Potassium

Potassium

SCHEMBL8043470

NS(=O)(=O)c1cccc(C(F)(F)F)c1.[K]

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 9/20 0.63
CA1 P00915 7/20 0.63
CA9 Q16790 5/20 0.63
CA12 O43570 3/20 0.63
MMP1 P03956 1/20 0.59
MMP2 P08253 1/20 0.59
MMP9 P14780 1/20 0.59
MMP8 P22894 1/20 0.59
MMP13 P45452 1/20 0.59
CA4 P22748 2/20 0.52
CA14 Q9ULX7 1/20 0.52
KIF11 P52732 1/20 0.52
KDM4E B2RXH2 1/20 0.51
GAA P10253 1/20 0.51
SLC6A2 P23975 1/20 0.49
SLC6A4 P31645 1/20 0.49
PTGES2 Q9H7Z7 1/20 0.49
CES2 O00748 1/20 0.48
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29705239 0.98 CA2 (0.65) CA2CA1CA9CA12MMP1
SCHEMBL962772 0.98 CA2 (0.65) CA2CA1CA9CA12MMP1
SCHEMBL8043466 0.96 CA2 (0.63) CA2CA1CA9CA12MMP1
SCHEMBL27811943 0.96 CA2 (0.63) CA2CA1CA9CA12MMP1
Hydrochloric Acid SCHEMBL29969413 0.96 CA2 (0.63) CA2CA1CA9CA12MMP1
Trifluoroacetic Acid SCHEMBL29695834 0.88 CA1 (0.63) CA2CA1CA9CA12MMP1
Benzoic Acid SCHEMBL22653517 0.84 SRD5A2 (0.61) CA2CA1CA9CA12MMP1
SCHEMBL8863056 0.82 CA1 (0.65) CA2CA1MMP1MMP2MMP9
SCHEMBL30859041 0.82 CA1 (0.65) CA2CA1MMP1MMP2MMP9
SCHEMBL12841398 0.81 CA2 (0.59) CA2CA1CA9CA12CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1086578-C Sulfonamides and their use HOFFMANN LA ROCHE (CH) 2002-06-26 CN disclosed
US-6030976-A SELECTIVE AFFINITY TO 5HT-6 RECEPTORS; CENTRAL NERVOUS SYSTEM DISORDERS; ALZHEIMER'S DISEASE, PSYCHOSES, SCHIZOPHRENIA, MANIC DEPRESSIONS, MEMORY DISORDERS, PARKINSON'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS AND HUNTINGTON'S DISEASE HOFFMAN-LA ROCHE INC. (US) 2000-02-29 US disclosed
US-5998665-A THERAPY FOR NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-12-07 US disclosed
US-5939451-A INDOL-4-YL-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-17 US disclosed
US-5932599-A 4-AMINO-N-(PYRIDINYL-4-YL)-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-03 US disclosed
CN-1170574-A Sulfonamides and their use HOFFMANN LA ROCHE (CH) 1998-01-21 CN disclosed